Nitrate plasma level as a marker of nitric oxide production after subcutaneous interleukin 2 immunotherapy.
Porta
C
C
Moroni
M
M
Bobbio-Pallavicini
E
E
Tinelli
C
C
Regazzi-Bonora
M
M
D015415:Biomarkers / Q000097:blood; D002292:Carcinoma, Renal Cell / Q000097:blood / Q000628:therapy*; D002851:Chromatography, High Pressure Liquid / Q000379:methods; D006801:Humans; D007167:Immunotherapy; D007376:Interleukin-2 / Q000008:administration & dosage / Q000627:therapeutic use*; D007680:Kidney Neoplasms / Q000097:blood / Q000628:therapy*; D009566:Nitrates / Q000097:blood*; D009569:Nitric Oxide / Q000096:biosynthesis*; D012680:Sensitivity and Specificity
D015415:Biomarkers; D007376:Interleukin-2; D009566:Nitrates; D009569:Nitric Oxide